# reload+after+2024-01-20 03:47:09.286654
address1§3800 Bridge Parkway
address2§Suite 102
city§Redwood City
state§CA
zip§94065
country§United States
phone§650 453 0000
website§https://seer.bio
industry§Biotechnology
sector§Healthcare
longBusinessSummary§Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic research, and clinical trials. The company intends to sell its products for research purposes, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. Seer, Inc. has a collaboration agreement with Oregon Health & Science University; The Broad Institute of MIT and Harvard; Discovery Life Sciences, LLC. and the Salk Institute for Biological Studies. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.
fullTimeEmployees§164
companyOfficers§[{'maxAge': 1, 'name': 'Dr. Omid C. Farokhzad M.D., Ph.D.', 'age': 54, 'title': 'Founder, CEO, & Chair of the Board of Directors', 'yearBorn': 1969, 'fiscalYear': 2022, 'totalPay': 1228793, 'exercisedValue': 0, 'unexercisedValue': 4952000}, {'maxAge': 1, 'name': 'Mr. David R. Horn', 'age': 56, 'title': 'President,Treasurer & CFO', 'yearBorn': 1967, 'fiscalYear': 2022, 'totalPay': 593381, 'exercisedValue': 0, 'unexercisedValue': 2084085}, {'maxAge': 1, 'name': 'Ms. Elona  Kogan Esq., J.D.', 'age': 54, 'title': 'Chief Legal Officer,General Counsel & Secretary', 'yearBorn': 1969, 'fiscalYear': 2022, 'totalPay': 548419, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Joe  Laws', 'title': 'Chief Technology Officer and Co-Founder', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Kenny  Ross', 'title': 'Chief Operations & Product Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Karen  Possemato', 'title': 'Chief Marketing Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Marissa  Dixon', 'title': 'Chief People Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Serafim  Batzoglou Ph.D.', 'title': 'Chief Data Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Martin  Goldberg Ph.D.', 'title': 'Senior Vice President of Development', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Asim  Siddiqui Ph.D.', 'title': 'Senior Vice President of Research & Tech Development', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
auditRisk§8
boardRisk§8
compensationRisk§10
shareHolderRightsRisk§10
overallRisk§10
governanceEpochDate§1704067200
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§1.614
priceToSalesTrailing12Months§6.94082
currency§USD
dateShortInterest§1702598400
forwardEps§-1.33
pegRatio§0.11
exchange§NMS
quoteType§EQUITY
shortName§Seer, Inc.
longName§Seer, Inc.
firstTradeDateEpochUtc§1607092200
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§83978bb5-a69b-3b5a-b7ba-eeadd8f768ba
gmtOffSetMilliseconds§-18000000
targetHighPrice§10.0
targetLowPrice§10.0
targetMeanPrice§10.0
targetMedianPrice§10.0
recommendationMean§2.7
recommendationKey§hold
numberOfAnalystOpinions§1
quickRatio§27.097
grossMargins§0.52294
ebitdaMargins§0.0
trailingPegRatio§None
